Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pulmonology
•
Critical Care
•
Hospital Medicine
Do you routinely start full dose anticoagulation in new onset atrial fibrillation in the ICU?
Answer from: at Community Practice
Yes. (Based on CHADS2 + Absence of absolute contraindications, i.e., active uncontrolled bleeding or coagulopathy.)
Sign In
or
Register
to read more
Case-to-case basis based on the underlying cause and bleeding risk. I don't as readily in patients where it's driven by sepsis: Walkey et al., PMID 27487456
Sign In
or
Register
to read more
17977
17979
Related Questions
When starting stress dose steroids for patient with primary adrenal insufficiency, how do you decide whether to start hydrocortisone 100 mg every 8 hours versus 50 mg every 6 hours?
Would you recommend starting tolvaptan at 7.5 mg per day, which is half the typical starting dose, to reduce the risk of overcorrection in an inpatient with SIADH and a serum sodium level of 122 mEq/L?
How do you decide whether to use pharmacologic VTE prophylaxis in hospitalized patients with decompensated cirrhosis?
When do you recommend limited or targeted respiratory pathogen testing versus a full respiratory pathogen panel in a patient presenting with URI symptoms?
Do you maintain a strict platelet threshold of >50k when performing a lumbar puncture, or are there situations in which you feel comfortable with a lower threshold?
What would be your approach to percutaneous intervention for acute plaque rupture and cardiogenic shock for a patient with cirrhosis and severe thrombocytopenia?
Are there factors that would prompt you to consider the use of methylene blue in refractory septic shock?
Do you routinely check an Allen's test before placing a radial arterial line?
How do you recommend incorporating B-lines on lung POCUS as part of evaluating a patient's volume status?
What are your thoughts on trending beta-hydroxybutyrate once a diagnosis of DKA is already established?